Dow Up 1.31% Nasdaq Up 2.40%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
50.65 Oct 21, 4:00PM EDT
Prev Close:50.65
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:84.80
Beta:1.56
Next Earnings Date:27-Oct-14LGND Earnings announcement
Day's Range:N/A - N/A
52wk Range:41.99 - 80.42
Volume:0
Avg Vol (3m):444,002
Market Cap:1.05B
P/E (ttm):140.30
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGND 0.00%1.05B
LLY69.32B
MRK159.03B
RHHBY247.27B

Key Statistics

Forward P/E (1 yr):21.10
P/S (ttm):19.38
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.54
Quarterly EPS Est (Sep-14) :0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback